Results 61 to 70 of about 18,522 (215)

High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA‐I Dysfunctionality

Lipids, 2012
AbstractThe relevance of serum apolipoprotein E (apoE) levels to two hypertriglyceridemic dyslipidemias has not been clarified. We explored, in a cross‐sectional (and short‐term prospective) evaluation, the independent relationship of serum apoE to the atherogenic dyslipidemia, hypertriglyceridemia with elevated apoB (HtgB) and to apoA‐I ...
Onat, Altan, Can, Günay, Örnek, Ender, Ayhan, Erkan, Erginel, Nihan Ünaltuna, Murat, Sani   +5 more
openaire   +3 more sources

The Role of Obesity in the Association Between Alcohol Consumption and HDL‐c Levels: Baependi Heart Study

Lipids, EarlyView.
ABSTRACT Cardiovascular diseases (CVD) are a leading cause of global mortality, with dyslipidemia playing a central role in their pathogenesis. The influence of alcohol consumption on lipid profiles, particularly high‐density lipoprotein cholesterol (HDL‐c), in relation to obesity status remains insufficiently explored.
Larissa Esthefani Barros Cirino, Divanei Zaniqueli, Oscar Geovanny Enriquez‐Martinez, Camila Maciel de Oliveira, Alexandre da Costa Pereira, Jordana Herzog Siqueira, Rafael de Oliveira Alvim   +6 more
wiley   +1 more source

Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies

, 2022
AIMS: Lower limb peripheral artery disease (PAD) is a leading cause of atherosclerotic cardiovascular disease (ASCVD). Discordant data are available on the association between apolipoprotein and PAD.
Tripaldella M., Forte F., Calcaterra I., Iannuzzo G., Lupoli R., Di Minno M. N. D., Chiurazzi M., Orsini R. C.   +7 more
core   +1 more source

Structure and interfacial properties of chicken apolipoprotein A-IV

Journal of Lipid Research, 2000
To gain insight into the evolution and function of apolipoprotein A-IV (apoA-IV) we compared structural and interfacial properties of chicken apoA-IV, human apoA-IV, and a recombinant human apoA-IV truncation mutant lacking the carboxyl terminus ...
Richard B. Weinberg, Rachel A. Anderson, Victoria R. Cook, Florence Emmanuel, Patrice Denefle, Marcela Hermann, Armin Steinmetz   +6 more
doaj   +1 more source

Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool [PDF]

Journal of Biological Chemistry, 1995
Elevated plasma high density lipoprotein cholesterol (HDL-C) levels are associated with a decreased risk for coronary heart disease. Ironically, diets enriched in saturated fat and cholesterol (HF/HC diets), which tend to accelerate atherosclerotic processes by increasing LDL cholesterol levels, also raise HDL-C.
N, Azrolan, H, Odaka, J L, Breslow, E A, Fisher   +3 more
openaire   +2 more sources

Therapeutic Potential of Berberis vulgaris in Modulating Metabolic Syndrome Biomarkers: Mechanistic Insights and Functional Food Implications

Food Frontiers, Volume 7, Issue 4, July 2026.
ABSTRACT Barberry (Berberis vulgaris) has emerged as a promising functional food candidate for the management of metabolic syndrome due to its diverse bioactive constituents, particularly berberine. This review synthesizes current experimental and clinical evidence regarding its effects on glycemic control, lipid metabolism, blood pressure regulation ...
Fakhar Shahid, Ifrah Jabeen, Muhammad Inam‐ur‐Raheem, Amin Mousavi Khaneghah, Muhammad Abid, Rana Muhammad Aadil   +5 more
wiley   +1 more source

ApoA-IMilano from structure to clinical application

, 2008
Apolipoprotein A-IMilano (apoA-IM) is characterized by a Cys for Arg substitution and formation of homo- and apoA-II heterodimers. In the last years, some important insights on apoA-IM have been provided, i.e.
L. Calabresi, C.R. Sirtori, E. Gianazza, I. Eberini   +3 more
core   +1 more source

Immunochemical characterization of six monoclonal antibodies to human apolipoprotein A-I: epitope mapping and expression.

Journal of Lipid Research, 1990
We have produced and characterized six murine monoclonal antibodies to human apolipoprotein A-I named A-I-9, A-I-12, A-I-15, A-I-16, A-I-19, and A-I-57. All monoclonal antibodies were specific for apolipoprotein A-I and bound between 55% and 100% of 125I-
S Marcovina, S Fantappie, A Zoppo, G Franceschini, AL Catapano   +4 more
doaj   +1 more source

Context‐Dependent Effects of Apolipoprotein A2 on Lipid Metabolism and Atherogenesis

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Proposed model of the pro‐atherogenic role of APOA2 in dyslipidemia. Under conditions of dyslipidemia (ldlr−/− and apoe−/− mice), APOA2 promotes a reduction in VLDL through its conversion to LDL via an LDLR‐independent pathway. LDL is then deposited to the aorta and aortic root. In the ldlr−/− mice, the presence of APOE may mitigate the rate of VLDL to
Evangelia Zvintzou, Ioana Madalina Fenyo, Radu Ionita, Georgia Kakafoni, Madalina Dumitrescu, Maria Alemi, Bianca Sanziana Daraban, Konstantinos Marinos, Anca Violeta Gafencu, Kyriakos E. Kypreos   +9 more
wiley   +1 more source

ApoA-I and Cancer

, 2015
High-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I), the predominant protein in plasma HDL, have long been the focus of intense studies in the field of atherosclerosis and cardiovascular disease (CVD). ApoA-I, in large part, is responsible for
Maryam eZamanian-Daryoush, Maryam Zamanian-Daryoush, Joseph A. DiDonato   +2 more
core   +1 more source